Compugen Ltd. (NASDAQ: CGEN) is 29.94% higher on its value in year-to-date trading and has touched a low of $0.51 and a high of $2.36 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CGEN stock was last observed hovering at around $0.82 in the last trading session, with the day’s gains setting it 0.11% off its average median price target of $5.50 for the next 12 months. It is also 92.85% off the consensus price target high of $13.00 offered by 6 analysts, but current levels are -86.0% lower than the price target low of $0.50 for the same period.
Currently trading at $0.93, the stock is 33.80% and 36.09% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.16 million and changing 13.28% at the moment leaves the stock 7.01% off its SMA200. CGEN registered -50.27% loss for a year compared to 6-month loss of 4.13%. The firm has a 50-day simple moving average (SMA 50) of -$2.06 and a 200-day simple moving average (SMA200) of $0.46.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
The stock witnessed a 55.00% gain in the last 1 month and extending the period to 3 months gives it a 24.00%, and is 20.92% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.89% over the week and 9.55% over the month.
Compugen Ltd. (CGEN) has around 69 employees, a market worth around $80.52M and $7.50M in sales. Distance from 52-week low is 82.35% and -60.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-45.60%).
Compugen Ltd. (CGEN) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Compugen Ltd. (CGEN) is a “Overweight”. 6 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.
Compugen Ltd. is expected to release its quarterly report on 08/03/2023.The EPS is expected to grow by 4.20% this year
Compugen Ltd. (CGEN) Top Institutional Holders
The shares outstanding are 86.62M, and float is at 81.78M with Short Float at 2.16%.
Compugen Ltd. (CGEN): Who are the competitors?
The company’s main competitors (and peers) include Seagen Inc. (SGEN) that is trading 40.25% up over the past 12 months and Teva Pharmaceutical Industries Limited (TEVA) that is -10.41% lower over the same period. Evogene Ltd. (EVGN) is -34.35% down on the 1-year trading charts.